Cathie Wood’s ARK Invest Sells Over 125,000 Shares of Iovance Bio
One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Wednesday. This fund sold over 125,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was flat on Wednesday. Note that this ETF is still up handily in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Wednesday’s closing price, this would have valued this sale at $3 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 37% in the past year.
Check out all of the ARK Invest sales for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 3690HK | MEITUAN | 1,342,426 |
| ARKF | 9923HK | YEAHKA | 339,600 |
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 1,339,400 |
| ARKG | SEER | SEER | 152,557 |
| ARKG | RHHBY | ROCHE | 66,000 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 16,223 |
| ARKG | BMY | BRISTOL-MYERS SQUIBB | 114,400 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 128,163 |
| ARKK | NTDOY | NINTENDO | 53,300 |
| ARKQ | XONE | EXONE | 82,333 |
| ARKW | LC | LENDINGCLUB | 164,932 |
| ARKW | NFLX | NETFLIX | 192 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
ALSO READ: Goldman Sachs Says Buy These 4 Top Oil Stocks With Huge 2022 Upside Potential
Get Our Free Investment Newsletter
Source: Read Full Article